The market has become an uncertain place. Neither equities nor bonds offer safety. Such times create opportunities.

REITs offer diversified, inflation-hedged income and capital appreciation, making them a compelling addition to any long-term investment portfolio. Current REIT valuations are attractive, with strong growth projected in sectors like data centers, industrial, net lease, and residential properties. I recommend focusing on quality REITs trading below historical multiples, emphasizing margin of safety and reliable dividend growth.

Agree Realty Corporation 4.250% DEP PFD A possesses a current yield of 6%+, a 200 basis point premium to Agree Realty's common shares. The REIT's growth outlook remains strong given the myriad of macro and credit-level challenges faced. Moreover, Agree Realty's leverage is relatively low and higher gearing remains a possibility. ADC.PR.A might not share in its fundamental growth factors, but its discount likely presents upside in itself, while fundamentals contribute to lower counterparty risk.

US equity markets surged this week - extending a dramatic post "Liberation Day" rebound - after the White House announced a trade truce with China, while investors cheered surprisingly cool inflation data. Quelling one of the primary recession risks, the U.S. and China reached a surprising breakthrough in agreeing to slash tariffs to pre-retaliation levels during a 90-day negotiating period. More good news on the inflation front. Despite the broad-based tariff hikes in April, the critical CPI and the PPI both showed the lowest annual increase in inflation since 2021.

I highlight five SWAN (Sleep Well At Night) REITs that pay monthly dividends and offer strong balance sheets, attractive yields, and growth potential. Realty Income, Healthpeak, Agree Realty, LTC Properties, and STAG Industrial are my top picks, each with well-covered dividends and favorable valuations. I caution against Gladstone Land due to its unsustainable payout ratio and negative earnings trend, labeling its yield a potential 'sucker yield.'

I focus on buying high-quality, high-yielding dividend growth stocks. When they go on sale, I pounce. I share two that are trading at highly compelling opportunities after recent pullbacks.

Ideaya Biosciences, Inc. is advancing darovasertib in a phase 2/3 trial for HLA-A2-negative metastatic uveal melanoma patients, with mPFS data expected by end of 2025. Ideaya plans a phase 3 study of darovasertib as a neoadjuvant for uveal melanoma, starting in the first half of 2025. IDE849 is an ADC targeting DLL3 in SCLC and NETs, This program has two catalysts: phase 1 data in Q3 2025 and a new study in H2 2025.

Inclusive of Prior Hedging Activity the All-In Interest Rate of the Notes is 5.35% ROYAL OAK, Mich. , May 14, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its operating partnership, Agree Limited Partnership (the "Operating Partnership"), priced a public offering of $400 million of its 5.600% senior unsecured notes due 2035 (the "Notes").

ZYNLONTA ®  plus glofitamab (COLUMVI®) demonstrated ORR of 95.5% and CR of 90.9%, among 22 evaluable patients with relapsed/refractory DLBCL Safety and tolerability data were consistent with the known profiles of each agent Updated data to be shared during poster presentation at EHA2025 on Saturday, June 14 at 12:30 p.m. ET and oral presentation at ICML on Friday, June 20 at 9:00 a.m.

Five publicly traded real estate investment trusts in the US announced increases to their regular dividend payments in April, according to S&P Global Market Intelligence data. The total number of publicly traded US REITs that have declared increases to their regular dividends during the first four months of 2025 is 40, representing more than a quarter of the sector. These entities include nine companies, or 47.4%, of the residential REIT industry as well as seven companies, or 38.9%, of the specialty REIT industry.